Drug class
Phenothiazine-derived dopamine D2 receptor antagonist; antiemetic
Mechanism of action
Blocks dopamine D2 receptors in the chemoreceptor trigger zone and other emetic pathways, reducing nausea and vomiting. It has limited antipsychotic activity at usual antiemetic doses.
General use cases
- Symptomatic treatment of nausea and vomiting with oral or rectal formulations where metopimazine is authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
